Main news


New Insights Into Mortality in Takotsubo Syndrome Quality of life for patients with acute heart failure (AHF) managed in a short-term unit (SSU) is no worse than that for those who are hospitalized, a new randomized trial showed. They also had an increased chance of being alive and out of hospital at 30 days and did not experience more adverse events, results suggested.



Study Identifies Cardiovascular Comorbidities Associated With Dermatomyositis Dermatomyositis (DM) is associated with an increased risk for cardiovascular comorbidities, including chronic kidney disease, a new study found.



High-Sensitivity Troponin Offers AMI Diagnostic Edge Implementing the high-sensitivity troponin (hsTn)-based HEART pathway in US emergency departments (EDs) improves acute myocardial infarction (AMI) diagnosis.



No Impact of Race on Cardiovascular Risk Calculations Removing race and incorporating social determinants of health (SDOH) into the pooled cohort risk equations (PCEs) for predicting atherosclerotic cardiovascular disease (ASCVD) outcomes made no difference to patients' risk scores.



Obesity Associated With More Severe Outcomes in Multisystem Inflammatory Syndrome in Children Obesity appears to be more prevalent in patients with multisystem inflammatory syndrome in children (MIS-C) than in children with Kawasaki disease, according to a new study. In addition, obesity is associated with more severe presentation, laboratory results, and outcomes of MIS-C than Kawasaki disease.



Alcohol and CV Risk: Both Beneficial and Harmful Effects? The relationship between alcohol consumption and cardiovascular disease (CVD) may be more nuanced than previously thought, with evidence emerging that alcohol use may both increase and decrease the risk for CVD.



SCD Mortality Rates Improved for Black Patients in 2010s The average age of death for Black U.S. patients with sickle cell disease (SCD) rose from 39 years (females = 40, males = 38) in 1999-2009 to 43 years (females = 44, males = 41) in 2010-2020, reflecting improvements in treatment, a new study finds.



Concordant Hypertension: Researchers Say Many Couples Share High Blood Pressure The research team, which examined middle-aged and older heterosexual couples across China, England, India and the U.S., observed concordance of hypertension, a situation when both partners have high blood pressure. If your partner has hypertension, you are likely to have it too, says researchers of a new study.



Early Menstruation Linked To Heightened Risk Of Type 2 Diabetes Later In Life: Study Getting periods before the age of 13 is linked to a heightened risk of developing type 2 diabetes later in life, a new study has found. The study, published in the journal BMJ Nutrition Prevention & Health, also suggests that girls who start menstruation before the age of 10 or younger are at an increased risk of having a stroke before the age of 65.



Sleep-disordered breathing and cardiovascular disease: who and why to test and how to intervene? Sleep-disordered breathing (SDB) is common in individuals with established cardiovascular disease (CVD), particularly those with heart failure (HF). There are two main types of SDB, central sleep apnoea (CSA) and obstructive sleep apnoea (OSA) which frequently overlap as mixed SDB.


World Red Cross Day and Red Crescent Day
World Red Cross Day and Red Crescent Day World Red Cross Day and Red Crescent Day is celebrated on 8 May every year. This date is the birth anniversary of Henry Dunant, who was born on 8 May 1828 at Geneva, Switzerland, and died on 30 October 1910 at Heiden, Switzerland. He was the founder of (ICRC) International Committee of the Red Cross and the recipient of the first Nobel Peace Prize in 1901.


Lower CVD Risk With Stable DMARD Therapy in Seropositive Rheumatoid Arthritis
Lower CVD Risk With Stable DMARD Therapy in Seropositive Rheumatoid Arthritis The risk for cardiovascular diseases (CVDs) is lower in patients with seropositive rheumatoid arthritis (RA) who remain on stable disease-modifying antirheumatic drug (DMARD) therapy than in those whose treatment regimen is not stable.


Editorial Activity

cardiology book

FDA Approves First Pulsed Field Ablation System for AF
FDA Approves First Pulsed Field Ablation System for AF The US Food and Drug Administration (FDA) has approved the PulseSelect Pulsed Field Ablation (PFA) System (Medtronic) for the treatment of both paroxysmal and persistent atrial fibrillation (AF), the manufacturer has announced.


A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic Syndrome
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic Syndrome A growing appreciation of the pathophysiological interrelatedness of metabolic risk factors such as obesity and diabetes, chronic kidney disease, and cardiovascular disease has led to the conceptualization of cardiovascular-kidney-metabolic syndrome. The confluence of metabolic risk factors and chronic kidney disease within cardiovascular-kidney-metabolic syndrome is strongly linked to risk for adverse cardiovascular and kidney outcomes.


In memory of Umida Kabirovna Kamilova
In memory of Umida Kabirovna Kamilova November 21, 2023. Passed away at the age of 61. Professor Umida Kabirovna Kamilova, Doctor of Medical Sciences. She devoted her life and work to medicine.


ACC/AHA Issue Updated Atrial Fibrillation Guideline
ACC/AHA Issue Updated Atrial Fibrillation Guideline The American College of Cardiology (ACC), the American Heart Association (AHA), the American College of Chest Physicians (ACCP), and the Heart Rhythm Society (HRS) have issued an updated guideline for preventing and optimally managing atrial fibrillation (AF).


One step closer to the new frontiers of healthcare for cardiomyopathy patients
One step closer to the new frontiers of healthcare for cardiomyopathy patients There were great advances in the treatment of heart failure (HF) over the past decades, characterised by the inclusion of ARNI and SGLT2 inhibitors in the latest guidelines. The use of cardiac myosin inhibitors specifically for patients with hypertrophic cardiomyopathy (HCM) is also making large steps forward, which reflects the next step towards more personalised treatment.


Roles for cardiologists in government, research councils and regulatory sectors
Roles for cardiologists in government, research councils and regulatory sectors Clinicians have numerous opportunities to gain experience in governmental or regulatory organisations, including health technology assessment bodies and payors. These organisations often seek advice from individuals with clinical experience and knowledge, and they increasingly engage with the clinical community on a regular basis. Cardiologists can also take on formal advisory roles, either through working groups or ad hoc and standing committees. Additionally, there may be part-time or full-time employment opportunities available, often providing leadership in research councils.


Al Stethoscope rolled out to 100 GP clinics to help diagnose heart failure
Al Stethoscope rolled out to 100 GP clinics to help diagnose heart failure GP clinics in London and Wales will receive an AI-powered tool as part of a trial to help improve the diagnosis of a deadly heart condition.


Classification Identifies Four Stages of Heart Attack
Classification Identifies Four Stages of Heart Attack The Canadian Cardiovascular Society (CCS) has developed a four-stage classification of acute atherothrombotic myocardial infarction (MI) based on the severity of the injury to the myocardium.